Evidence map›Paper›PMID 41301014›Full record

ArticleCancers2025

Serological Response Patterns to Assess Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Multi-Center Observational Cohort Study.

Alessandra I G Buma, Femke Laarakker, Frederik A van Delft, Milou M F Schuurbiers, Jasper Smit, Antonius E van Herwaarden, Huub H van Rossum, Michel M van den Heuvel

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alessandra I G BumaDepartment of Respiratory Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.ORCID 0009-0003-7896-9890
Femke LaarakkerDepartment of Respiratory Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Frederik A van DelftDepartment of Laboratory Medicine, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0003-3428-6468
Milou M F SchuurbiersDepartment of Respiratory Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Jasper SmitDepartment of Thoracic Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Antonius E van HerwaardenDepartment of Laboratory Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-5417-8272
Huub H van RossumDepartment of Laboratory Medicine, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Michel M van den HeuvelDepartment of Respiratory Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-6372-2153

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical decision-makingimmune checkpoint inhibitorsnon-small cell lung cancerprognostic biomarkersresponse classificationserum tumor markers

Identifiers

PMID41301014
PMCPMC12651941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.